| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,139 |
4,612 |
$501K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,659 |
1,603 |
$149K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
976 |
948 |
$123K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
789 |
763 |
$66K |
| 99215 |
Prolong outpt/office vis |
74 |
71 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
440 |
430 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
17 |
16 |
$6K |
| 99354 |
|
48 |
45 |
$3K |
| 86328 |
|
60 |
60 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
115 |
111 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
256 |
239 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
73 |
73 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
17 |
$877.36 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
168 |
165 |
$349.21 |
| 99441 |
|
18 |
16 |
$236.56 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
17 |
15 |
$109.60 |
| 81025 |
|
14 |
13 |
$74.91 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
30 |
28 |
$30.31 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
17 |
15 |
$18.12 |
| 81002 |
|
134 |
120 |
$9.85 |
| 81003 |
|
85 |
81 |
$5.70 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
16 |
14 |
$0.03 |